Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 111 | $37,268,986 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 Mar 2025 17:47 | RYTM | RHYTHM PHARMACEUTICALS Inc | GERMAN CHRISTOPHER PAUL | Corporate Controller & CAO | 21 Mar 2025 | Sale | 344 | 54.23 | 18,655 | D |
18 Mar 2025 21:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | MAZABRAUD YANN | EVP, Head of International | 14 Mar 2025 | Sale | 19,197 | 50.7916 | 975,046 | D |
18 Mar 2025 21:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | MAZABRAUD YANN | EVP, Head of International | 14 Mar 2025 | Sale | 55,803 | 51.7217 | 2,886,226 | D |
19 Feb 2025 21:50 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 19 Feb 2025 | Sale | 2,215 | 57.22 | 126,742 | D |
19 Feb 2025 21:49 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 19 Feb 2025 | Sale | 1,228 | 57.22 | 70,266 | D |
19 Feb 2025 21:48 | RYTM | RHYTHM PHARMACEUTICALS Inc | MEEKER DAVID P | President and CEO | 19 Feb 2025 | Sale | 9,896 | 57.22 | 566,249 | D |
19 Feb 2025 21:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 19 Feb 2025 | Sale | 2,035 | 57.22 | 116,443 | D |
19 Feb 2025 21:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | GERMAN CHRISTOPHER PAUL | Corporate Controller & CAO | 19 Feb 2025 | Sale | 635 | 57.22 | 36,335 | D |
19 Feb 2025 21:43 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 19 Feb 2025 | Sale | 982 | 57.22 | 56,190 | D |
14 Feb 2025 16:59 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 12 Feb 2025 | Sale | 739 | 56.39 | 41,672 | D |
14 Feb 2025 16:59 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 12 Feb 2025 | Sale | 12 | 56.22 | 675 | D |
14 Feb 2025 16:57 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 12 Feb 2025 | Sale | 462 | 56.39 | 26,052 | D |
14 Feb 2025 16:57 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 12 Feb 2025 | Sale | 7 | 57.09 | 400 | D |
14 Feb 2025 16:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 12 Feb 2025 | Sale | 600 | 56.39 | 33,834 | D |
14 Feb 2025 16:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 12 Feb 2025 | Sale | 10 | 56.41 | 564 | D |
14 Feb 2025 16:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 12 Feb 2025 | Sale | 1,205 | 56.39 | 67,950 | D |
14 Feb 2025 16:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 13 Feb 2025 | Sale | 1,205 | 58 | 69,890 | D |
11 Feb 2025 21:47 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 11 Feb 2025 | Sale | 791 | 57.51 | 45,490 | D |
11 Feb 2025 21:47 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 11 Feb 2025 | Sale | 3 | 57.54 | 173 | D |
11 Feb 2025 21:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 10 Feb 2025 | Sale | 1,894 | 58.3928 | 110,596 | D |
11 Feb 2025 21:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 10 Feb 2025 | Sale | 2,295 | 59.3408 | 136,187 | D |
11 Feb 2025 21:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Feb 2025 | Sale | 1,023 | 57.51 | 58,833 | D |
11 Feb 2025 21:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Feb 2025 | Sale | 4 | 57.5 | 230 | D |
11 Feb 2025 21:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 11 Feb 2025 | Sale | 698 | 57.51 | 40,142 | D |
11 Feb 2025 21:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 11 Feb 2025 | Sale | 3 | 57.54 | 173 | D |
11 Feb 2025 21:44 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 11 Feb 2025 | Sale | 1,291 | 57.51 | 74,245 | D |
11 Feb 2025 21:44 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 11 Feb 2025 | Sale | 5 | 57.53 | 288 | D |
07 Feb 2025 17:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 05 Feb 2025 | Sale | 1,733 | 60.0811 | 104,121 | D |
07 Feb 2025 17:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 05 Feb 2025 | Sale | 1,133 | 61.0147 | 69,130 | D |
07 Feb 2025 17:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 05 Feb 2025 | Sale | 200 | 61.95 | 12,390 | D |
04 Feb 2025 21:27 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 04 Feb 2025 | Sale | 1,678 | 59.43 | 99,724 | D |
04 Feb 2025 21:26 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 04 Feb 2025 | Sale | 1,281 | 59.43 | 76,130 | D |
04 Feb 2025 21:25 | RYTM | RHYTHM PHARMACEUTICALS Inc | MEEKER DAVID P | President and CEO | 04 Feb 2025 | Sale | 4,278 | 59.43 | 254,242 | D |
04 Feb 2025 21:23 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 04 Feb 2025 | Sale | 1,447 | 59.43 | 85,995 | D |
04 Feb 2025 21:22 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 04 Feb 2025 | Sale | 902 | 59.43 | 53,606 | D |
13 Nov 2024 21:04 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Nov 2024 | Sale | 38,051 | 65.6763 | 2,499,049 | D |
13 Nov 2024 21:04 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Nov 2024 | Sale | 17,540 | 66.9484 | 1,174,275 | D |
13 Nov 2024 21:04 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Nov 2024 | Sale | 11,070 | 67.5585 | 747,873 | D |
13 Nov 2024 21:04 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 11 Nov 2024 | Sale | 200 | 68.43 | 13,686 | D |
13 Nov 2024 21:02 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 11 Nov 2024 | Sale | 6,604 | 65.7291 | 434,075 | D |
13 Nov 2024 21:02 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 11 Nov 2024 | Sale | 5,977 | 67.054 | 400,782 | D |
13 Nov 2024 21:02 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 11 Nov 2024 | Sale | 700 | 67.8343 | 47,484 | D |
08 Nov 2024 16:15 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 06 Nov 2024 | Sale | 4,687 | 60 | 281,220 | D |
08 Nov 2024 16:15 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 07 Nov 2024 | Sale | 4,688 | 65 | 304,720 | D |
19 Sep 2024 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | GOOD JENNIFER L | Director | 17 Sep 2024 | Sale | 31,751 | 52.4016 | 1,663,803 | D |
11 Sep 2024 16:32 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 09 Sep 2024 | Sale | 4,099 | 50.0274 | 205,062 | D |
11 Sep 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 10 Sep 2024 | Sale | 350 | 50.5986 | 17,710 | D |
11 Sep 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 10 Sep 2024 | Sale | 8,661 | 50.2016 | 434,796 | D |
11 Sep 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 10 Sep 2024 | Sale | 8,490 | 49.048 | 416,418 | D |
11 Sep 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 09 Sep 2024 | Sale | 3,199 | 50.0369 | 160,068 | D |
11 Sep 2024 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | GOOD JENNIFER L | Director | 09 Sep 2024 | Sale | 37,241 | 50.4471 | 1,878,700 | D |
28 Aug 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 26 Aug 2024 | Sale | 3,200 | 50.0056 | 160,018 | D |
28 Aug 2024 16:31 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 26 Aug 2024 | Sale | 4,300 | 50.0067 | 215,029 | D |
28 Aug 2024 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | GOOD JENNIFER L | Director | 26 Aug 2024 | Sale | 14,508 | 50.0087 | 725,526 | D |
14 Aug 2024 16:15 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 12 Aug 2024 | Sale | 407 | 45.3717 | 18,466 | D |
14 Aug 2024 16:15 | RYTM | RHYTHM PHARMACEUTICALS Inc | TETRAULT LYNN A. | Director | 12 Aug 2024 | Sale | 9,593 | 44.6154 | 427,996 | D |
13 Aug 2024 16:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 09 Aug 2024 | Sale | 2,104 | 45.6221 | 95,989 | D |
13 Aug 2024 16:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 09 Aug 2024 | Sale | 46,902 | 45.1262 | 2,116,509 | D |
30 Jul 2024 17:09 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 29 Jul 2024 | Sale | 1,395 | 49.06 | 68,439 | D |
18 Jul 2024 17:59 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 16 Jul 2024 | Sale | 10,468 | 53.0012 | 554,817 | D |
16 Jul 2024 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 12 Jul 2024 | Sale | 5,313 | 50.0141 | 265,725 | D |
13 May 2024 16:21 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 May 2024 | Sale | 500 | 39.102 | 19,551 | D |
13 May 2024 16:21 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 May 2024 | Sale | 3,484 | 38.3776 | 133,708 | D |
03 Apr 2024 20:00 | RYTM | RHYTHM PHARMACEUTICALS Inc | GERMAN CHRISTOPHER PAUL | Corporate Controller & CAO | 02 Apr 2024 | Sale | 368 | 41.76 | 15,368 | D |
22 Mar 2024 16:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 21 Mar 2024 | Sale | 18,235 | 40.34 | 735,600 | D |
22 Mar 2024 16:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 20 Mar 2024 | Sale | 9,066 | 39.33 | 356,566 | D |
22 Mar 2024 16:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 20 Mar 2024 | Sale | 9,169 | 38.22 | 350,439 | D |
19 Mar 2024 20:57 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 19 Mar 2024 | Sale | 15,515 | 39.22 | 608,498 | D |
19 Mar 2024 20:56 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 19 Mar 2024 | Sale | 15,515 | 39.22 | 608,498 | D |
19 Mar 2024 20:54 | RYTM | RHYTHM PHARMACEUTICALS Inc | MEEKER DAVID P | President and CEO | 19 Mar 2024 | Sale | 45,494 | 39.22 | 1,784,275 | D |
19 Mar 2024 20:53 | RYTM | RHYTHM PHARMACEUTICALS Inc | MAZABRAUD YANN | EVP, Head of International | 19 Mar 2024 | Sale | 16,000 | 39.22 | 627,520 | D |
19 Mar 2024 20:52 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 19 Mar 2024 | Sale | 15,515 | 39.22 | 608,498 | D |
19 Mar 2024 20:50 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 19 Mar 2024 | Sale | 15,515 | 39.22 | 608,498 | D |
15 Feb 2024 18:14 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 14 Feb 2024 | Sale | 1,089 | 50.01 | 54,461 | D |
15 Feb 2024 18:14 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 13 Feb 2024 | Sale | 1,865 | 50 | 93,250 | D |
13 Feb 2024 20:50 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 13 Feb 2024 | Sale | 709 | 49.82 | 35,322 | D |
13 Feb 2024 20:50 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 12 Feb 2024 | Sale | 1,209 | 51.38 | 62,118 | D |
13 Feb 2024 20:49 | RYTM | RHYTHM PHARMACEUTICALS Inc | MAZABRAUD YANN | EVP, Head of International | 13 Feb 2024 | Sale | 957 | 49.84 | 47,697 | D |
13 Feb 2024 20:49 | RYTM | RHYTHM PHARMACEUTICALS Inc | MAZABRAUD YANN | EVP, Head of International | 12 Feb 2024 | Sale | 1,594 | 51.38 | 81,900 | D |
13 Feb 2024 20:47 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 13 Feb 2024 | Sale | 615 | 49.83 | 30,645 | D |
13 Feb 2024 20:47 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 12 Feb 2024 | Sale | 1,023 | 51.38 | 52,562 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 13 Feb 2024 | Sale | 473 | 49.84 | 23,574 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 12 Feb 2024 | Sale | 791 | 51.38 | 40,642 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 Feb 2024 | Sale | 100 | 51.52 | 5,152 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 Feb 2024 | Sale | 23,397 | 50.8827 | 1,190,503 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 Feb 2024 | Sale | 48,177 | 50.1381 | 2,415,503 | D |
13 Feb 2024 20:46 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 09 Feb 2024 | Sale | 100 | 48.24 | 4,824 | D |
13 Feb 2024 20:45 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 12 Feb 2024 | Sale | 696 | 51.38 | 35,760 | D |
05 Feb 2024 18:55 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 01 Feb 2024 | Sale | 1,492 | 45.06 | 67,230 | D |
05 Feb 2024 18:54 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 01 Feb 2024 | Sale | 1,616 | 45.06 | 72,817 | D |
05 Feb 2024 18:54 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 01 Feb 2024 | Sale | 1,324 | 45.06 | 59,659 | D |
05 Feb 2024 18:53 | RYTM | RHYTHM PHARMACEUTICALS Inc | MEEKER DAVID P | President and CEO | 01 Feb 2024 | Sale | 4,361 | 45.06 | 196,507 | D |
05 Feb 2024 18:53 | RYTM | RHYTHM PHARMACEUTICALS Inc | CRAMER PAMELA J. | Chief Human Resources Officer | 01 Feb 2024 | Sale | 946 | 45.06 | 42,627 | D |
29 Dec 2023 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 28 Dec 2023 | Sale | 7,926 | 50.0023 | 396,318 | D |
29 Dec 2023 16:30 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 27 Dec 2023 | Sale | 5,015 | 50.0092 | 250,796 | D |
07 Dec 2023 16:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 05 Dec 2023 | Sale | 7,026 | 35.064 | 246,360 | D |
07 Dec 2023 16:16 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 06 Dec 2023 | Sale | 20,000 | 40 | 800,000 | D |
28 Nov 2023 16:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | SMITH HUNTER C | Chief Financial Officer | 24 Nov 2023 | Sale | 10,974 | 35.0224 | 384,336 | D |
16 Nov 2023 16:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | SHULMAN JOSEPH | Chief Technical Officer | 14 Nov 2023 | Sale | 27,890 | 32.0663 | 894,329 | D |
16 Nov 2023 16:05 | RYTM | RHYTHM PHARMACEUTICALS Inc | LEE JENNIFER KAYDEN | EVP, Head of North America | 14 Nov 2023 | Sale | 13,677 | 32.0113 | 437,819 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)